<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39434115</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6963</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>BMC health services research</Title><ISOAbbreviation>BMC Health Serv Res</ISOAbbreviation></Journal><ArticleTitle>Provider and community perceptions of integrated COVID-19 and routine childhood immunisation programmes in Nigeria: a qualitative exploratory study.</ArticleTitle><Pagination><StartPage>1262</StartPage><MedlinePgn>1262</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1262</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12913-024-11623-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In Nigeria, COVID-19 vaccines were delivered through outreach activities, as well as integrated within routine immunisation. However, evaluations of integrated approaches for novel vaccines are scarce. We aimed to understand the perceived benefits and challenges of integrating the COVID-19 vaccine within routine immunisation in Nigeria, and identify ways to strengthen this approach.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted 30 semi-structured interviews with community members and healthcare workers in primary healthcare facilities (PHCs) in Jigawa (n = 16) and Oyo (n = 14) states, Nigeria from 08 August to 13 September 2022. Participants were selected purposively from PHCs. We obtained information on participants' perception about routine immunisation, and perceived benefits and challenges associated with integrated COVID-19 vaccine delivery. Healthcare worker and community interviews were analysed separately following a thematic analysis approach.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified four themes that describe the community and healthcare workers' responses, perceived impact, and the health system adaptions to the challenges associated with the integrated vaccine delivery approach. Community members expressed concern that children might be given COVID-19 vaccines instead of routine immunisations, while others appreciated the integrated approach due to their trust in the efficacy of COVID-19 vaccines, government, and healthcare providers. Healthcare providers perceived the integrated approach as improving vaccination coverage and awareness but noted additional problems of increased workload, vaccine scarcity, and prolonged clinic visits. Insufficient resources were subsisting barriers to effective integration in both states, but the provider's gender was also a challenge in Jigawa state. Additionally, the use of incentives to generate demand had ambiguous effects in Jigawa state.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Taking an integrated approach to deliver COVID-19 vaccines was acceptable by healthcare providers but community members expressed concerns. Given existing vaccination programmes have persistent challenges, it is pertinent to address these barriers to enhance effectiveness of an integrated approach.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bakare</LastName><ForeName>Ayobami A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden. bakare.ayobami.adebayo@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Community Medicine, University College Hospital, Ibadan, Nigeria. bakare.ayobami.adebayo@ki.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akinsola</LastName><ForeName>Kofoworola O</ForeName><Initials>KO</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, University College Hospital, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Carina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sogbesan</LastName><ForeName>Abiodun A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, University College Hospital, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakare</LastName><ForeName>Oluwabunmi R</ForeName><Initials>OR</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, University College Hospital, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fadahunsi</LastName><ForeName>Opeyemi Y</ForeName><Initials>OY</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, University College Hospital, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salako</LastName><ForeName>Julius</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, University College Hospital, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falade</LastName><ForeName>Adegoke G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, University College Hospital, Ibadan, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Paediatrics, College of Medicine, University of Ibadan, Ibadan, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Herzig van Wees</LastName><ForeName>Sibylle</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020-04737</GrantID><Agency>Swedish Research Council</Agency><Country /></Grant><Grant><GrantID>2020-04737</GrantID><Agency>Swedish Research Council</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Health Serv Res</MedlineTA><NlmUniqueID>101088677</NlmUniqueID><ISSNLinking>1472-6963</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009549" MajorTopicYN="N" Type="Geographic">Nigeria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="Y">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="Y">Immunization Programs</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007407" MajorTopicYN="N">Interviews as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001291" MajorTopicYN="N">Attitude of Health Personnel</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">Childhood immunisation</Keyword><Keyword MajorTopicYN="N">Essential health services</Keyword><Keyword MajorTopicYN="N">Health systems</Keyword><Keyword MajorTopicYN="N">Integrated vaccine delivery</Keyword><Keyword MajorTopicYN="N">Nigeria</Keyword><Keyword MajorTopicYN="N">Preventive care</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>7</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>23</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39434115</ArticleId><ArticleId IdType="pmc">PMC11492757</ArticleId><ArticleId IdType="doi">10.1186/s12913-024-11623-7</ArticleId><ArticleId IdType="pii">10.1186/s12913-024-11623-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shang W, Wang Y, Yuan J, Guo Z, Liu J, Liu M. Global excess mortality during COVID-19 pandemic: a systematic review and Meta-analysis. Vaccines. 2022;10(10). 10.3390/vaccines10101702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9607451</ArticleId><ArticleId IdType="pubmed">36298567</ArticleId></ArticleIdList></Reference><Reference><Citation>Doshi RH, Nsasiirwe S, Dahlke M, et al. COVID-19 Vaccination Coverage — World Health Organization African Region, 2021–2023. MMWR Morb Mortal Wkly Rep. 2024;73(14):307–11. 10.15585/MMWR.MM7314A3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11008790</ArticleId><ArticleId IdType="pubmed">38602879</ArticleId></ArticleIdList></Reference><Reference><Citation>Africa CDC. COVID-19 Vaccination – Africa CDC. Accessed 10 Jul 2024. https://africacdc.org/covid-19-vaccination/</Citation></Reference><Reference><Citation>NPHCDA. Nigeria 11.7% short of COVID-19 vaccination target. Published 2023. Accessed 10 Jul 2024. https://punchng.com/nigeria-11-7-short-of-covid-19-vaccination-target/#google_vignette</Citation></Reference><Reference><Citation>WHO. Nigerians in situation of vulnerability to benefit from COVID-19 vaccination scale-up and integration through Canadian grant | WHO | Regional Office for Africa. Published 2023. Accessed 10 Jul 2024. https://www.afro.who.int/countries/nigeria/news/nigerians-situation-vulnerability-benefit-covid-19-vaccination-scale-and-integration-through</Citation></Reference><Reference><Citation>Ogunniyi TJ, Rufai BO, Uketeh SN, Turzin JK, Oyinloye EA, Effiong FB. Two years of COVID-19 vaccination in Nigeria: a review of the current situation of the pandemic: a literature review. Ann Med Surg. 2023;85(11):5528–32. 10.1097/ms9.0000000000001310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10617854</ArticleId><ArticleId IdType="pubmed">37915653</ArticleId></ArticleIdList></Reference><Reference><Citation>NCDC. COVID-19 Situation Report: Situation Report 95. Niger Cent Dis Control. 2021;95(June):1–4. https://ncdc.gov.ng/themes/common/files/sitreps/fe61a5d7bba46e835a7f6d09bd5343c8.pdf</Citation></Reference><Reference><Citation>WHO, United Nations. COVID-19 pandemic fuels largest continued backslide in vaccinations in three decades. Published 2022. Accessed 10 Jul 2024. https://www.who.int/news/item/15-07-2022-covid-19-pandemic-fuels-largest-continued-backslide-in-vaccinations-in-three-decades</Citation></Reference><Reference><Citation>GAVI. From equality to global poverty: how Covid-19 is affecting societies and economies. Published 2020. Accessed 10 Jul 2024. https://www.gavi.org/vaccineswork/equality-global-poverty-how-covid-19-affecting-societies-and-economies</Citation></Reference><Reference><Citation>WHO. States adopt integrated vaccination strategy to reach unimmunized children. | WHO | Regional Office for Africa. Published 2022. Accessed 10 Jul 2024. https://www.afro.who.int/countries/nigeria/news/states-adopt-integrated-vaccination-strategy-reach-unimmunized-children</Citation></Reference><Reference><Citation>Kozlowska O, Lumb A, Tan GD, Rea R. Barriers and facilitators to integrating primary and specialist healthcare in the United Kingdom: a narrative literature review. Futur Healthc J. 2018;5(1):64–80. 10.7861/futurehosp.5-1-64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6510038</ArticleId><ArticleId IdType="pubmed">31098535</ArticleId></ArticleIdList></Reference><Reference><Citation>Offor C, Ade-Banjo O, Nwankwo C, et al. Evidence for Whole Family Approach in accelerating uptake of COVID-19 and routine immunizations among integrated primary health services in Nigeria. Front Heal Serv. 2023;3(May):1–9. 10.3389/frhs.2023.1157377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10232860</ArticleId><ArticleId IdType="pubmed">37275182</ArticleId></ArticleIdList></Reference><Reference><Citation>Shet A, Carr K, Danovaro-Holliday MC, et al. Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories. Lancet Glob Heal. 2022;10(2):e186–94. 10.1016/S2214-109X(21)00512-X.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691849</ArticleId><ArticleId IdType="pubmed">34951973</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangura JB, Xiao S, Qiu D, Ouyang F, Chen L. Barriers to childhood immunization in sub-saharan Africa: a systematic review. BMC Public Health. 2020;20(1). 10.1186/s12889-020-09169-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362649</ArticleId><ArticleId IdType="pubmed">32664849</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual Res Sport Exerc Heal. 2019;11(4):589–97. 10.1080/2159676X.2019.1628806.</Citation></Reference><Reference><Citation>Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Heal Care. 2007;19(6):349–57. 10.1093/INTQHC/MZM042.</Citation><ArticleIdList><ArticleId IdType="pubmed">17872937</ArticleId></ArticleIdList></Reference><Reference><Citation>NPC, Oyo. (State, Nigeria) - Population Statistics, Charts, Map and Location. Published 2022. Accessed 10 Jul 2024. https://citypopulation.de/en/nigeria/admin/NGA031__oyo/</Citation></Reference><Reference><Citation>GDL. Mean International Wealth Index (IWI) score of region - Area Database - Table - Global Data Lab. Published 2023. Accessed 10 Jul 2024. https://globaldatalab.org/areadata/table/iwi/NGA/?levels=1+4</Citation></Reference><Reference><Citation>United Nations Children’s Fund (UNICEF), (NBS) NB of S. About | National Bureau of Statistics. Published 2022. Accessed 10 Jul 2024. https://nigerianstat.gov.ng/news/77</Citation></Reference><Reference><Citation>NPC, Jigawa. (State, Nigeria) - Population Statistics, Charts, Map and Location. Published 2022. Accessed 10 Jul 2024. https://www.citypopulation.de/en/nigeria/admin/NGA018__jigawa/</Citation></Reference><Reference><Citation>Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Soc Sci Med. 2022;292:114523. 10.1016/J.SOCSCIMED.2021.114523.</Citation><ArticleIdList><ArticleId IdType="pubmed">34785096</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham HR, Maher J, Bakare AA, et al. Oxygen systems and quality of care for children with pneumonia, malaria and diarrhoea: analysis of a stepped-wedge trial in Nigeria. PLoS ONE. 2021;16(7 July):1–17. 10.1371/journal.pone.0254229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8266122</ArticleId><ArticleId IdType="pubmed">34237107</ArticleId></ArticleIdList></Reference><Reference><Citation>King C, Burgess RA, Bakare AA, et al. Integrated sustainable childhood pneumonia and infectious disease reduction in Nigeria (INSPIRING) through whole system strengthening in Jigawa, Nigeria: study protocol for a cluster randomised controlled trial. Trials. 2022;23(1):1–13. 10.1186/s13063-021-05859-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8802253</ArticleId><ArticleId IdType="pubmed">35101109</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon C, McDonnell T, Barrett M, et al. The impact of the COVID-19 pandemic on child health and well-being: are children slipping through the net ? A qualitative study of frontline emergency care staff. BMC Health Serv Res. 2021;9(1):1–29. 10.1186/s12913-021-06284-9. https://bmchealthservres.biomedcentral.com/articles/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7993902</ArticleId><ArticleId IdType="pubmed">33766026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanma-Okafor O, Odusolu Y, Abayomi A, et al. A qualitative analysis of the COVID-19 vaccination rollout in Lagos, Nigeria: client and provider perspectives on the plan, the process and the progress. PLOS Glob Public Heal. 2022;2(11):1–19. 10.1371/journal.pgph.0000486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10021997</ArticleId><ArticleId IdType="pubmed">36962511</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojewale LY, Mukumbang FC. COVID-19 vaccine hesitancy among nigerians living with non-communicable diseases: a qualitative study. BMJ Open. 2023;13(2). 10.1136/bmjopen-2022-065901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9895914</ArticleId><ArticleId IdType="pubmed">36731928</ArticleId></ArticleIdList></Reference><Reference><Citation>Dash S, Parray AA, De Freitas L, et al. Combating the COVID-19 infodemic: a three-level approach for low and middle-income countries. BMJ Glob Heal. 2021;6(1):1–5. 10.1136/bmjgh-2020-004671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849320</ArticleId><ArticleId IdType="pubmed">33514596</ArticleId></ArticleIdList></Reference><Reference><Citation>Abad N, Uba BV, Patel P, et al. A rapid qualitative assessment of barriers associated with demand and uptake of health facility-based childhood immunizations and recommendations to improve immunization service delivery in Sokoto State, Northwest Nigeria, 2017. Pan Afr Med J. 2021;40(Suppl 1):10. 10.11604/PAMJ.SUPP.2021.40.1.23793.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9475061</ArticleId><ArticleId IdType="pubmed">36157555</ArticleId></ArticleIdList></Reference><Reference><Citation>Babalola S. Maternal reasons for non-immunisation and partial immunisation in northern Nigeria. J Paediatr Child Health. 2011;47(5):276–81. 10.1111/j.1440-1754.2010.01956.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">21244560</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdullahi S. Factors affecting completion of childhood immunization in North West Nigeria. Walden Univ Diss Dr Stud Collect. 2019;80(3-B(E)). https://scholarworks.waldenu.edu/cgi/viewcontent.cgi?article=7095&amp;context=dissertations</Citation></Reference><Reference><Citation>Bennett NG, Bloom DE, Ferranna M. Factors underlying COVID-19 vaccine and booster hesitancy and refusal, and incentivizing vaccine adoption. PLoS ONE. 2022;17(9 September):1–11. 10.1371/journal.pone.0274529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9498968</ArticleId><ArticleId IdType="pubmed">36136997</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazanov GK, Stewart R, Pieri MF, et al. The effectiveness of financial incentives for COVID-19 vaccination: a systematic review. Prev Med (Baltim). 2023;172(January). 10.1016/j.ypmed.2023.107538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10163939</ArticleId><ArticleId IdType="pubmed">37156430</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwalbe N, Hanbali L, Nunes MC, Lehtimaki S. Use of financial incentives to increase adult vaccination coverage: a narrative review of lessons learned from COVID-19 and other adult vaccination efforts. Vaccine X. 2022;12:100225. 10.1016/j.jvacx.2022.100225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9535879</ArticleId><ArticleId IdType="pubmed">36217357</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO, UNICEF. Considerations for integrating COVID-19 vaccination into immunization. Published 2023. Accessed 11 Jul 2024. https://www.who.int/publications/i/item/9789240064454</Citation></Reference><Reference><Citation>Aigbogun EO, Ibrahim R, Yusufari Y, et al. Impact of the COVID-19 pandemic on Routine Immunization Programs in Northern Nigeria. Sustain. 2023;15(17). 10.3390/su151712966.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>